Tandem Diabetes Care, Inc. (TNDM) Reports Q1 Loss, Tops Revenue Estimates
Tandem Diabetes Care (TNDM) delivered earnings and revenue surprises of +34.78% and +3.46%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?